Soleno Therapeutics Inc (SLNO)
Financing Cash Flow
$132.72M
TTM · Period ending: · USD
SLNO Financing Cash Flow
Latest reported$132.72Mperiod ending
Latest reported$132.72Mperiod ending
SLNO TTM Cash from Financing ($0.00 → $132.72M)
TTM financing cash flow
High-resolution chart · PNG
SLNO financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 132,722,001 | |
| 136,983,000 | |
| 293,946,000 | |
| 78,245,000 | |
| 215,305,000 | |
| 213,025,000 | |
| 279,520,000 | |
| 316,646,000 | |
| 180,957,000 | |
| 180,019,000 | |
| 56,461,000 | |
| 17,402,000 | |
| 60,000 | |
| 14,092,000 | |
| 14,087,000 | |
| 13,745,000 | |
| 14,029,000 | |
| -128,000 | |
| -165,000 | |
| -360,000 | |
| 53,601,000 | |
| 53,722,000 | |
| 68,245,000 | |
| 68,440,000 | |
| 14,477,000 | |
| 14,481,000 | |
| 16,302,000 | |
| 17,002,000 | |
| 17,539,000 | |
| 17,827,000 | |
| 15,469,687 | |
| 14,769,687 | |
| 14,232,687 | |
| 23,944,687 | |
| 9,999,133 | |
| 15,698,133 | |
| 15,768,133 | |
| 10,768,133 | |
| 14,953,920 | |
| 10,563,920 | |
| 10,775,920 | |
| 9,157,920 | |
| 14,452,985 | |
| 13,258,104 | |
| 14,580,485 | |
| 11,202,985 | |
| 1,723,000 | |
| 1,608,721 | |
| 4,500 | |
| 0 |